Bristol-Myers Squibb Company has had a recent 30% stock decline amid concerns over patent expirations. Click here to read why BMY stock is a Hold.

Linda Klonsky usually orders her prescription eye drops from a Canadian pharmacy that charges $250 for a three-month supply.

Prior research has suggested that 7% to 8% of patients with AMD develop hemorrhagic complications. In this study, the use of anticoagulants or antiplatelets was linked to a higher risk of intraocular ...

(Reuters) -Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to diversify from legacy products ...

Deion Sanders may be dealing with blood clots again. Sanders coached much of Colorado’s 35-21 loss to TCU without a shoe on his left foot. After the game he said it was because his foot was in so much ...

Scientists have converted the blood type of a donor kidney and transplanted the organ into a person. The procedure — the first of its kind — could improve access to donor organs, specialists say, ...

WASHINGTON (AP) — Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar ...

President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.

Its products also include several cancer drugs, the blood thinner Eliquis and Prevnar pneumonia vaccines. Under the deal, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and ...

Pfizer agrees to lower drug costs for Medicaid and invest $70 billion in US manufacturing, aligning with the Trump administration's push to reduce healthcare expenses and boost domestic production.

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.The announcement, ...